Unfortunately, even with the use of US contrast agents, there is considerable overlap in the appearance of metastases and hepatocellular ... colon, pancreas, or ovary (Fig. 8). Thyroid carcinoma ...
First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. This is an ASCO Meeting Abstract from the 2025 ...
This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...
Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...
A cancer that ... to detect hepatocellular cancer at any stage. Baylor Medicine offers patients access to specialists in all areas of care for liver cancer. Patients with cancer that has spread from ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
in treatment naïve patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC). These data are being presented at the 2025 ASCO Gastrointestinal Cancers Symposium ...
Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback